For the fourth year running—and the third in a row for Skyrizi specifically—an AbbVie immunology med has claimed the top spot in the full-year TV drug ad spending rankings, as calculated by iSpot.TV.

Feb 4 (Reuters) - AbbVie forecast 2026 profit above Wall Street estimates on Wednesday after posting a fourth-quarter results beat, fueled by strong demand for newer immunology drugs Skyrizi and ...

AbbVie and Medtronic have a long history of raising their dividends and continue to have healthy free cash flow for further ...

Merck MRK and AbbVie ABBV are leading pharmaceutical players with entrenched franchises in oncology and immunology. Beyond these core areas, AbbVie has built a presence in aesthetics, neuroscience and ...

The first two days of the J.P. Morgan Healthcare Conference are in the books, and attendees are now pushing through to finish strong. Today, UCB, AbbVie and Legend Biotech are among the companies ...

These stocks offer impressive long-term upside with downside protection.

CEO Rob Michael highlighted an excellent start to 2025, with adjusted EPS of $2.46, exceeding the guidance midpoint by $0.10, and total revenues surpassing $13.3 billion, driven by a 21% growth in the ...

Olivia Dean capped her rapid ascent from London busker to breakout global star on Sunday by winning the 2026 Grammy for best new artist, a career‑defining honor that has historically signaled the ...

Music hits the big screen... When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Directed by Antoine Fuqua, the highly anticipated Michael will focus ...